Attached files

file filename
EX-99.1 - EX-99.1 - UNITED SURGICAL PARTNERS INTERNATIONAL INCd82390exv99w1.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 19, 2011
 
UNITED SURGICAL PARTNERS INTERNATIONAL, INC.
(Exact name of Registrant as specified in its charter)
         
Delaware
(State or other
jurisdiction of incorporation)
  333-144337
(Commission File Number)
  75-2749762
(I.R.S. Employer
Identification Number)
     
15305 Dallas Parkway
Suite 1600
Addison, Texas

(Address of principal
executive offices)
  75001
(Zip code)
Registrant’s telephone number, including area code: (972) 713-3500
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 7.01 Regulation FD Disclosure.
     Attached hereto is a presentation made by a senior officer of United Surgical Partners International, Inc. (the “Company”) on May 19, 2011 at the UBS Leveraged Finance Conference in New York City, New York. A copy of the presentation is attached hereto as Exhibit 99.1. These materials are also available on the Company’s website at www.uspi.com.
     In accordance with General Instruction B.2. of Form 8-K, the information furnished in this report on Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
  99.1   Presentation by the Company made on May 19, 2011 at the UBS Leveraged Finance Conference in New York City, New York
SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
         
  UNITED SURGICAL PARTNERS
INTERNATIONAL, INC.
 
 
  By:   /s/ Mark A. Kopser    
    Mark A. Kopser   
    Executive Vice President and
Chief Financial Officer
(Principal Financial Officer and duly authorized
to sign this report on behalf of the Registrant)
 
 
 
Date: May 19, 2011

 


 

EXHIBIT INDEX
     
Exhibit    
Number   Description
99.1
  Presentation by the Company made on May 19, 2011 at the UBS Leveraged Finance Conference in New York City, New York